Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
NCT00190047 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2007-11-26
Summary
This study will examine if DP-b99 can improve neurological function (for example strength and coordination) in the 3 months after an acute stroke
Conditions
- Brain Ischemia
- Stroke
- Cerebrovascular Disorders
Interventions
- DRUG
-
DP-b99
Sponsors & Collaborators
-
D-Pharm Ltd.
lead INDUSTRY
Principal Investigators
-
Gilad Rosenberg, M.D. · D-Pharm Ltd.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Completion
- 2006-10-31
Countries
- Germany
- Israel
Study Locations
More Related Trials
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
NCT00856661 ·Status: TERMINATED ·Phase: PHASE3
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
DNS-3379 vs. Placebo in Stroke Rehabilitation
NCT03254160 ·Status: TERMINATED ·Phase: PHASE2
-
Beta Blockers In Acute Ischemic Stroke
NCT01061190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
Donepezil Trial for Motor Recovery in Acute Stroke
NCT01442766 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke
NCT00663338 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
NCT02251197 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
NCT02586233 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
NCT01883011 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
NCT01800357 ·Status: UNKNOWN ·Phase: PHASE2
-
Dapsone for Acute Ischemia Stroke Study
NCT01144650 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database
NCT05817097 ·Status: UNKNOWN
-
DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
NCT07241897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Phase Ib/II in Patients With Acute Ischemic Stroke
NCT02963376 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
NCT02121327 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
NCT01790997 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
NCT04890366 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
NCT06987643 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Study of Interferon Beta 1a to for Acute Stroke
NCT00097318 ·Status: COMPLETED ·Phase: PHASE1
-
Mildronate for Acute Ischemic Stroke
NCT01831011 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
NCT00119626 ·Status: COMPLETED ·Phase: PHASE3